- Home
- BMRA vs VINC Comparison
BMRA vs VINC Comparison
Compare BMRA & VINC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- VINC
- Stock Information
- Founded
- BMRA 1971
- VINC 2019
- Country
- BMRA United States
- VINC United States
- Employees
- BMRA N/A
- VINC N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- VINC Biotechnology: Pharmaceutical Preparations
- Sector
- BMRA Health Care
- VINC Health Care
- Exchange
- BMRA Nasdaq
- VINC Nasdaq
- Market Cap
- BMRA 7.4M
- VINC 6.2M
- IPO Year
- BMRA N/A
- VINC N/A
- Fundamental
- Price
- BMRA $0.30
- VINC $0.19
- Analyst Decision
- BMRA
- VINC Buy
- Analyst Count
- BMRA 0
- VINC 2
- Target Price
- BMRA N/A
- VINC $2.00
- AVG Volume (30 Days)
- BMRA 2.3M
- VINC 564.7K
- Earning Date
- BMRA 01-14-2025
- VINC 11-12-2024
- Dividend Yield
- BMRA N/A
- VINC N/A
- EPS Growth
- BMRA N/A
- VINC N/A
- EPS
- BMRA N/A
- VINC N/A
- Revenue
- BMRA $5,509,000.00
- VINC N/A
- Revenue This Year
- BMRA N/A
- VINC N/A
- Revenue Next Year
- BMRA N/A
- VINC N/A
- P/E Ratio
- BMRA N/A
- VINC N/A
- Revenue Growth
- BMRA 1.74
- VINC N/A
- 52 Week Low
- BMRA $0.24
- VINC $0.18
- 52 Week High
- BMRA $1.51
- VINC $9.37
- Technical
- Relative Strength Index (RSI)
- BMRA 47.80
- VINC 28.60
- Support Level
- BMRA $0.27
- VINC $0.19
- Resistance Level
- BMRA $0.48
- VINC $0.23
- Average True Range (ATR)
- BMRA 0.04
- VINC 0.03
- MACD
- BMRA -0.00
- VINC 0.00
- Stochastic Oscillator
- BMRA 23.86
- VINC 9.21
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.
About VINC Vincerx Pharma Inc.
Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are conducted in the United States. It focuses on developing, using, manufacturing, commercializing, sublicensing, and distributing a clinical-stage and follow-on small molecule drug program and a preclinical-stage bioconjugation/next-generation ADC platform.